Citation Impact
Citing Papers
Cetuximab Attenuates Its Cytotoxic and Radiosensitizing Potential by Inducing Fibronectin Biosynthesis
2013
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
JNK Regulates HIPK3 Expression and Promotes Resistance to Fas-mediated Apoptosis in DU 145 Prostate Carcinoma Cells
2004
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
2016 Standout
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
2001
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
2006 Standout
Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1
1998
Nuclear RNA export
1998 StandoutNobel
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Protective Role for c-Jun in the Cellular Response to DNA Damage
2001
Regulation of Platinum-Compound Cytotoxicity by the c-Jun N-Terminal Kinase and c-Jun Signaling Pathway in Small-Cell Lung Cancer Cells
2002
Wound repair and regeneration
2008 StandoutNature
Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NFκB-dependent Pathway
2006
The role of glutathione-S-transferase in anti-cancer drug resistance
2003
Virus-like particles in vaccine development
2010
Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development
1998
β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes
2000 StandoutNobel
Lack of c‐Jun activity increases survival to cisplatin
1999
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
2003
Cellular response to oxidative stress: Signaling for suicide and survival*
2002 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Cellular and molecular determinants of cisplatin resistance
1998
The Early-Immediate Gene EGR-1 Is Induced by Transforming Growth Factor-β and Mediates Stimulation of Collagen Gene Expression
2006
Cellular processing of platinum anticancer drugs
2005 Standout
Requirement for ERK Activation in Cisplatin-induced Apoptosis
2000
Cisplatin resistance and oncogenes - a review
2000
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
The identification and characterization of microsatellites in the compact genome of the japanese pufferfish, Fugu rubripes: perspectives in functional and comparative genomic analyses
1998
Inhibition of the RelA(p65) NF-κB Subunit by Egr-1
2000
Autophagy in Human Health and Disease
2013 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosis
2000
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Local force and geometry sensing regulate cell functions
2006 Standout
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line
1999
Generation and Analysis of 25 Mb of Genomic DNA from the Pufferfish Fugu rubripes by Sequence Scanning
1999 StandoutNobel
Autophagic Protein LC3B Confers Resistance against Hypoxia-induced Pulmonary Hypertension
2010
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex
2008
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma1
2006
The Human Copper-Zinc Superoxide Dismutase Gene (SOD1) Proximal Promoter Is Regulated by Sp1, Egr-1, and WT1 via Non-canonical Binding Sites
1999
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Hypertonic Induction of Aquaporin-5 Expression through an ERK-dependent Pathway
2000 StandoutNobel
MOM-4, a MAP Kinase Kinase Kinase–Related Protein, Activates WRM-1/LIT-1 Kinase to Transduce Anterior/Posterior Polarity Signals in C. elegans
1999 StandoutNobel
Mechanisms of resistance to cisplatin
2001
Life Span Extension by Calorie Restriction Depends on Rim15 and Transcription Factors Downstream of Ras/PKA, Tor, and Sch9
2008
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells
2006
Selective Pharmacologic Inhibition of c-Jun NH 2 -Terminal Kinase Radiosensitizes Thyroid Anaplastic Cancer Cell Lines via Induction of Terminal Growth Arrest
2006
How do fibroblasts translate mechanical signals into changes in extracellular matrix production?
2003
All-trans-Retinoic Acid Inhibits Jun N-Terminal Kinase by Increasing Dual-Specificity Phosphatase Activity
1999
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
The Stress Kinase Mitogen-Activated Protein Kinase Kinase (Mkk)7 Is a Negative Regulator of Antigen Receptor and Growth Factor Receptor–Induced Proliferation in Hematopoietic Cells
2001 StandoutNobel
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
2000 StandoutScience
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
2001 Standout
Resistance of keratinocytes to TGFβ-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds
2002
Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines
2000
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity
2004
Early Growth Response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia.
2002
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
1999
Mechanosignaling to the Cell Nucleus and Gene Regulation
2011
The Jun Kinase 2 Isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells
1999
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
2002 StandoutScience
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Critical nodes in signalling pathways: insights into insulin action
2006 Standout
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
1999 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Mechanical stress is communicated between different cell types to elicit matrix remodeling
2001
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation
2001 Standout
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Hallucinogens
2004 Standout
Works of Chaoting Liu being referenced
The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-β1, Fibronectin, and Plasminogen Activator Inhibitor-1
1999
The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251
2000
p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis
1999
Transient Transfection Factors for High-Level Recombinant Protein Production in Suspension Cultured Mammalian Cells
2008
The Jun Kinase/Stress-activated Protein Kinase Pathway Functions to Regulate DNA Repair and Inhibition of the Pathway Sensitizes Tumor Cells to Cisplatin
1997
EGR-1, The Reluctant Suppression Factor:
1996
EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
1996